S&P 500
5,911.69
-0.0%
-$0.48
DJI
42,270.07
+0.1%
+$54.34
NASDAQ
19,113.77
-0.3%
-$62.11
Bitcoin
105,613.00
+0.9%
+910.31
AAPL
$201.47
+0.8%
+$1.52
AMZN
$205.07
-0.3%
-$0.63
GOOG
$173.06
+0.1%
+$0.10
META
$648.23
+0.5%
+$3.18
MSFT
$460.71
+0.4%
+$2.03
NVDA
$135.22
-2.9%
-$3.97
TSLA
$346.82
-3.2%
-$11.61
Max Macaluso
TMFMassimo
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Recent Articles by Max Macaluso
Dec 31, 2013
by Max Macaluso and Rex Moore
How Mobile Technology Is Changing Medicine As We Know It
mHealth, or mobile health, could be one of the biggest buzzwords of 2014. But what is this fledgling field all about, and why are tech companies like Qualcomm and Verizon becoming major players in the health-care space?
Dec 15, 2013
by Max Macaluso
What Will the Fitbit Look Like in 5 Years?
Consumer demand for activity trackers is rising, and companies in this space continue to innovate. However, looking ahead over the next five years, what can companies like Fitbit come up with to help consumers monitor their health? What will Fitbit's devices be able to in the future?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.